Maharashtra Scooters Limited FY2026 Financial Results and Dividend Announcement
Maharashtra Scooters Limited has announced its financial results for the year ended 31 March 2026, reporting a robust profit after tax of…
HealthCare Global Enterprises Limited Compliance Disclosure for Quarter Ended March 2026
HealthCare Global Enterprises Limited has successfully fulfilled its compliance requirements regarding security dematerialization for the…
Transformers and Rectifiers (India) Limited Reports Strong FY26 Performance with 23% Revenue Growth
Transformers and Rectifiers (India) Limited (TARIL) has announced robust financial results for the fiscal year 2026. The company achieved a…
Bharat Dynamics Limited Board Announces Departure of Independent Director
Bharat Dynamics Limited has officially announced the conclusion of the tenure of its Part-time Non-Official Independent Director, Shri Chetan…
Larsen & Toubro L&T Energy GreenTech Partners with Japan’s ITOCHU for Green Ammonia Supply
L&T Energy GreenTech Ltd (LTEGL), a subsidiary of Larsen & Toubro, has signed a landmark long-term partnership with Japan’s ITOCHU…
Deutsche Bank Release of Encumbrance on YES Bank Limited Shares
Deutsche Bank AG has announced the full release of encumbrance over a significant block of shares held by Verventa Holdings Ltd (VHL) in YES…
Sterling and Wilson Renewable Energy Settlement Reached in Legal Proceedings
Sterling and Wilson Renewable Energy Limited has announced a successful resolution to the legal proceedings regarding the encashment of a…
Varroc Engineering Limited Sustainability Milestones and Kham River Restoration Efforts
Varroc Engineering Limited has reaffirmed its sustainability commitment, marked by a surge in its ESG rating to 75 and improved EcoVadis…
RBL Bank Deepak Kumar Re-appointed as Chief Risk Officer
RBL Bank has officially announced the re-appointment of Mr. Deepak Kumar as its Chief Risk Officer. This extension marks a further six-month…
Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the U.S.
Lupin Limited has announced the U.S. launch of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets. This medication, approved…